• Home
  • About Us
  • Core Focus
  • Structure
    • Governance
    • Meet the team
  • Initiatives
    • Time Off Treatment New
    • European Policy Brief Launch New
    • ECLLA Policy Roundtable
    • ECLLA Club
  • Membership
    • Members
    • Tiers
  • News
    • ECLLA News
    • Newsletters
  • Contact Us
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
📰 ECLLA Newsletter – October 2026 Edition Now Available

📰 ECLLA Newsletter – October 2026 Edition Now Available

Oct 15, 2026 | homepage-featured, News, Newsletter

The European CLL Association (ECLLA) is pleased to announce the release of the October 2026 edition of the ECLLA Newsletter. In this edition, we share some exciting milestones as ECLLA continues to grow and strengthen its European network. You’ll find highlights...
📢 ECLLA Publishes European Policy Brief 2026 and Launches It at the European Parliament

📢 ECLLA Publishes European Policy Brief 2026 and Launches It at the European Parliament

Oct 1, 2026 | ECLLA Policy Roundtabe, homepage-featured, News

The European CLL Association (ECLLA) has published its European Policy Brief 2026, setting out key priorities and recommendations to help address inequalities in chronic lymphocytic leukaemia (CLL) care across Europe. The Brief was formally launched on 30 September...
Invitation: Policy Dialogue at the European Parliament & Launch of ECLLA’s European Policy Brief | 30 September 2026 – REGISTRATION OPEN

Invitation: Policy Dialogue at the European Parliament & Launch of ECLLA’s European Policy Brief | 30 September 2026 – REGISTRATION OPEN

Sep 21, 2026 | ECLLA Policy Roundtabe, News

Dear members and friends, We are pleased to invite you to join us for Blood Cancers and CLL on the European Agenda: From Recognition to Action, a high-level multi-stakeholder policy dialogue hosted by MEP Regina Doherty and organised by the European CLL Association...
🎓 ECLLA CLUB: Join Our Second Educational Session “Immune Health in CLL” September, 29th – REGISTRATION OPEN

🎓 ECLLA CLUB: Join Our Second Educational Session “Immune Health in CLL” September, 29th – REGISTRATION OPEN

Sep 11, 2026 | ECLLA Club, homepage-featured, News

Dear ECLLA Members, We are pleased to invite you to our second ECLLA Club session: Immune Health in CLL. This interactive session will feature an expert-led presentation by Dr Lydia Scarfò, Assistant Professor of Internal Medicine & Consultant Haematologist,...
📢 ECLLA Launches New European Insight Paper on Time Off Treatment in CLL

📢 ECLLA Launches New European Insight Paper on Time Off Treatment in CLL

Sep 2, 2026 | homepage-featured, News

New ECLLA European Holistic Framework explores how people living with CLL can be supported before, during and after fixed-duration treatment   The European CLL Association (ECLLA) is pleased to launch its new European Insight Paper, Time Off Treatment in CLL: The...
Let’s Mark Blood Cancer Awareness Month Together: Share Your September Activities

Let’s Mark Blood Cancer Awareness Month Together: Share Your September Activities

Aug 24, 2026 | News

Dear ECLLA Members, We are looking forward to Blood Cancer Awareness Month this September and to highlighting ECLLA’s activities, alongside the many initiatives taking place across our member community to raise awareness of CLL and blood cancers. As we finalise...
« Older Entries

Recent Posts

  • 📰 ECLLA Newsletter – October 2026 Edition Now Available
  • 📢 ECLLA Publishes European Policy Brief 2026 and Launches It at the European Parliament
  • Invitation: Policy Dialogue at the European Parliament & Launch of ECLLA’s European Policy Brief | 30 September 2026 – REGISTRATION OPEN
  • 🎓 ECLLA CLUB: Join Our Second Educational Session “Immune Health in CLL” September, 29th – REGISTRATION OPEN
  • 📢 ECLLA Launches New European Insight Paper on Time Off Treatment in CLL

Recent Comments

No comments to show.
© European CLL Association (ECLLA) | Privacy Policy | Policies and Disclaimers | All rights reserved
Accessibility Adjustments

Powered by OneTap

How long do you want to hide the toolbar?
Hide Toolbar Duration
Select your accessibility profile
Vision Impaired Mode
Enhances website's visuals
Seizure Safe Profile
Clear flashes & reduces colour
ADHD Friendly Mode
Focused browsing, distraction-free
Blindness Mode
Reduces distractions, improves focus
Epilepsy Safe Mode
Dims colours and stops blinking
Content Modules
Font Size

Default

Line Height

Default

Colour Modules
Orientation Modules